Older adults are at increased risk of hospital admission, intensive care unit admission, and death due to respiratory syncytial virus (RSV)1 Most people experience mild RSV reinfections throughout ...

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study in ...

Respiratory illnesses like influenza, COVID-19 and Respiratory Syncytial Virus (RSV) are known to spread more rapidly during ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...

Respiratory illnesses like influenza, COVID-19 and Respiratory Syncytial Virus (RSV) are known to spread more rapidly during ...

Vaccines for respiratory syncytial virus (RSV) can reduce hospitalization and costs for older adults, and vaccination programs focused on patients with underlying medical conditions appear to be ...

Clinicians and healthcare professionals should target adults aged 70 and over with underlying health conditions instead of the general population, when it comes to efforts to reduce spending and ...

RSV infections affect a significant number of children under age 5, with considerable disease burden in primary care and emergency departments.

The North Carolina Department of Health and Human Services (NCDHHS) is encouraging residents to get their seasonal flu shot.

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a ...